Interestingly, and in contrast to our expectations, trametinib and ICG-001 appear to work synergistically in the CTNNB1-wild type colon cancer cell line SW620 (Fig 8A), and not in the CTNNB1-mutant cell line (Fig 8B). This evidence concerns the gene CTNNB1 and malignant colon neoplasm.